FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 292:1214-1217 June 5, 1975 Number 23 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

Saralasin, an angiotensin antagonist, was used to study the role of renin-angiotensin in the vasodilator-beta-blocker drug interaction in hypertensive subjects. Plasma renin activity was elevated by withdrawal of propranolol in seven patients using minoxidil and propranolol. After propranolol withdrawal, saralasin caused hypotension (100/60 mm Hg or less) in five. Propranolol lowered blood pressure and plasma renin activity and diminished the hypotensive response to saralasin. Saralasin induced renin release in all patients, an effect blocked by propranolol. We conclude that angiotensin can be the major determinant of blood pressure in vasodilator-drug treated patients, that propranolol lowering of blood pressure in this vasodilator-beta-blocker drug interaction is related to suppression of renin release, and that the angiotensin feed-back-suppression mechanism for inhibiting renin release in functionally located proximal to beta-adrenergic receptors mediating renin release.

This article has been cited by other articles:

• Goossens, G. H., Jocken, J. W.E., Blaak, E. E., Schiffers, P. M., Saris, W. H.M., van Baak, M. A. (2007). Endocrine Role of the Renin-Angiotensin System in Human Adipose Tissue and Muscle: Effect of {beta}-Adrenergic Stimulation. Hypertension 49: 542-547 [Abstract] [Full Text]  
• Stefanec, T. (2000). Endothelial Apoptosis: Could It Have a Role in the Pathogenesis and Treatment of Disease?. Chest 117: 841-854 [Abstract] [Full Text]  
• Dignat-George, F., Blann, A., Sampol, J. (2000). Circulating endothelial cells in acute coronary syndromes. Blood 95: 728-728 [Full Text]  
• Stefanec, T. (1999). Circulating Apoptotic Endothelial Cells. Blood 94: 1482-1483 [Full Text]  
• Johnston, G. D., Pettinger, W. A., Lee, H.-C., Paulshock, B. Z., Materson, B. J., Reda, D. J., Cushman, W. C., Rouse, C. F. (1993). Single-Drug Therapy for Hypertension in Men. NEJM 329: 1043-1045 [Full Text]  
• Cotorruelo, J. G., Llamazares, C., Florez, J. (1982). Minoxidil in Severe and Moderately Severe Hypertension, in Association with Methyldopa and Chlortalidone. ANGIOLOGY 33: 710-719 [Abstract]  
• Lijnen, P.J., Amery, A.K., Fagard, R.H., Reybrouck, T.M. (1978). Relative Significance of Plasma Renin Activity and Concentration in Physiologic and Pathophysiologic Conditions. ANGIOLOGY 29: 354-366  
• Sambhi, M. P., Eggena, P., Barrett, J. D., Thananopavarn, C., Tuck, M., Wiedeman, C. (1977). Antihypertensive and Renin Angiotensin Effects Of Metolazone With and Without Propranolol. J Clin Pharmacol 17: 214-224